Ontology of the apelinergic system in mouse pancreas during pregnancy and relationship with β-cell mass.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 07 2021
Historique:
received: 11 04 2021
accepted: 15 07 2021
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 15 12 2021
Statut: epublish

Résumé

The apelin receptor (Aplnr) and its ligands, Apelin and Apela, contribute to metabolic control. The insulin resistance associated with pregnancy is accommodated by an expansion of pancreatic β-cell mass (BCM) and increased insulin secretion, involving the proliferation of insulin-expressing, glucose transporter 2-low (Ins

Identifiants

pubmed: 34326390
doi: 10.1038/s41598-021-94725-0
pii: 10.1038/s41598-021-94725-0
pmc: PMC8322410
doi:

Substances chimiques

Apelin 0
Apelin Receptors 0
Insulin 0
Intercellular Signaling Peptides and Proteins 0
Interleukin-6 0
apelin-13 peptide 0
interleukin-6, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15475

Informations de copyright

© 2021. The Author(s).

Références

Van Assche, F. A., Aerts, L. & De Prins, F. A morphological study of the endocrine pancreas in human pregnancy. Br. J. Obstet. Gynaecol. 85, 818–820 (1978).
pubmed: 363135 doi: 10.1111/j.1471-0528.1978.tb15835.x
Butler, A. E. et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 53, 2167–2176 (2010).
pubmed: 20523966 pmcid: 2931643 doi: 10.1007/s00125-010-1809-6
Xiang, A. et al. Longitudinal changes in insulin sensitivity and beta-cell function between women with and without a history of gestational diabetes mellitus. Diabetologia 56, 2753–2760 (2013).
pubmed: 24030069 pmcid: 4139094 doi: 10.1007/s00125-013-3048-0
Lorenzo, P. I., Martín-Montalvo, A., Cobo Vuilleumier, N. & Gauthier, B. R. Molecular modelling of islet β-cell adaptation to inflammation in pregnancy and gestational diabetes mellitus. Int. J. Mol. Sci. 20, 6171. https://doi.org/10.3390/ijms20246171 (2019).
doi: 10.3390/ijms20246171 pmcid: 6941051
Yang, Y. et al. Functional defects of regulatory T cell through interleukin 10 mediated mechanism in the induction of gestational diabetes mellitus. DNA Cell. Biol. 37, 278–285 (2018).
pubmed: 29298097 doi: 10.1089/dna.2017.4005
Vitoratos, N. et al. Pre- and early post-partum adiponectin and Interleukin-1beta levels in women with and without gestational diabetes. Hormones 7, 230–236 (2018).
doi: 10.14310/horm.2002.1202
Chen, L., Chen, R., Wang, H. & Liang, F. Mechanisms linking inflammation to insulin resistance. Int. J. Endocrinol. 2015, 1–9 (2015).
Sorenson, R. L. & Brelje, T. C. Adaptation of islets of Langerhans to pregnancy: Beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm. Metab. Res. 29, 301–307 (1997).
pubmed: 9230352 doi: 10.1055/s-2007-979040
Parsons, J. A., Brelje, T. C. & Sorenson, R. L. Adaptation of islets of Langerhans to pregnancy: Increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 130, 1459–1466 (1992).
pubmed: 1537300
Newbern, D. & Freemark, M. Placental hormones and the control of maternal metabolism and fetal growth. Curr. Opin. Endocrinol. Diabetes Obes. 18, 409–416 (2011).
pubmed: 21986512 doi: 10.1097/MED.0b013e32834c800d
Vasavada, R. C. et al. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J. Biol. Chem. 275, 15399–153406 (2000).
pubmed: 10809775 doi: 10.1074/jbc.275.20.15399
Huang, C., Snider, F. & Cross, J. C. Prolactin receptor is required for normal glucose homeostasis and modulation of β-cell mass during pregnancy. Endocrinology 150, 1618–1626 (2009).
pubmed: 19036882 doi: 10.1210/en.2008-1003
Brelje, T. C., Stout, L. E., Bhagroo, N. V. & Sorenson, R. L. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of Langerhans. Endocrinology 145, 4162–4175 (2004).
pubmed: 15142985 doi: 10.1210/en.2004-0201
Finegood, D. T., Scaglia, L. & Bonner-Weir, S. Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44, 249–256 (1995).
pubmed: 7883109 doi: 10.2337/diab.44.3.249
Bader, E. et al. Identification of proliferative and mature beta-cells in the islets of Langerhans. Nature 535, 430–434 (2016).
pubmed: 27398620 doi: 10.1038/nature18624
Chen, H. et al. PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature 478, 349–355 (2011).
pubmed: 21993628 pmcid: 3503246 doi: 10.1038/nature10502
Seaberg, R. M. et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22, 1115–1124 (2004).
pubmed: 15322557 doi: 10.1038/nbt1004
Smukler, S. R. et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell 8, 281–293 (2011).
pubmed: 21362568 doi: 10.1016/j.stem.2011.01.015
Beamish, C. A., Strutt, B. J., Arany, E. J. & Hill, D. J. Insulin-positive, Glut2-low cells present within mouse pancreas exhibit lineage plasticity and are enriched within extra-islet endocrine cell clusters. Islets 8, 65–82 (2016).
pubmed: 27010375 pmcid: 4987018 doi: 10.1080/19382014.2016.1162367
Beamish, C. A., Zhang, L., Szlapinski, S. K., Strutt, B. S. & Hill, D. J. An increase in immature β-cells lacking Glut2 precedes the expansion of β-cell mass in the pregnant mouse. PLoS One 12, e0182256. https://doi.org/10.1371/journal.pone.0182256 (2017).
doi: 10.1371/journal.pone.0182256 pubmed: 28753672 pmcid: 5533342
Szlapinski, S. et al. A mouse model of gestational glucose intolerance through exposure to a low protein diet during fetal and neonatal development. J. Physiol. 597, 4237–4250 (2019).
pubmed: 31206692 doi: 10.1113/JP277884
Nielsen, L. R., Rehfeld, J. F., Pedersen-Bjergaard, U., Damm, P. & Mathiesen, E. R. Pregnancy-induced rise in serum C-peptide concentration in women with type 1 diabetes. Diabetes Care 32, 1052–1057 (2009).
pubmed: 19244092 pmcid: 2681014 doi: 10.2337/dc08-1832
Cantley, J. The control of insulin secretion by adipokines: Current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis. Mamm. Genome 25, 442–454 (2014).
pubmed: 25146550 doi: 10.1007/s00335-014-9538-7
Deng, C., Chen, H., Yang, N., Feng, Y. & Hsueh, A. J. Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling. J. Biol. Chem. 290, 18261–18268 (2015).
pubmed: 25995451 pmcid: 4513087 doi: 10.1074/jbc.M115.648238
Zhang, J. et al. The orphan G protein-coupled receptor 25 (GPR25) is activated by Apelin and Apela in non-mammalian vertebrates. Biochem. Biophys. Res. Commun. 501, 408–414 (2018).
pubmed: 29727602 doi: 10.1016/j.bbrc.2018.04.229
Ladeiras-Lopes, R., Ferreira-Martins, J. & Leite-Moreira, A. The apelinergic system: The role played in human physiology and pathology and potential therapeutic applications. Arq. Bras. Cardiol. 90, 343–349 (2008).
pubmed: 18516406
Mayeur, S. et al. Apelin controls fetal and neonatal glucose homeostasis and is altered by maternal undernutrition. Diabetes 65, 54–560 (2015).
Eberlé, D. et al. Elabela and apelin actions in healthy and pathological pregnancies. Cytokine Growth Factor Rev. 46, 45–53 (2019).
pubmed: 30910349 doi: 10.1016/j.cytogfr.2019.03.003
Van Mieghem, T. et al. Apelin in normal pregnancy and pregnancies complicated by placental insufficiency. Reprod. Sci. 23, 1037–1043 (2016).
pubmed: 26880769 doi: 10.1177/1933719116630422
Van Mieghem, T. et al. Maternal apelin physiology during rat pregnancy: The role of the placenta. Placenta 31, 725–730 (2010).
pubmed: 20580085 doi: 10.1016/j.placenta.2010.06.001
O’Carroll, A., Lolait, S. J., Harris, L. E. & Pope, G. R. The apelin receptor APJ: Journey from an orphan to a multifaceted regulator of homeostasis. J. Endocrinol. 219, R13-35 (2013).
pubmed: 23943882 doi: 10.1530/JOE-13-0227
Yue, P. et al. Apelin is necessary for the maintenance of insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 298, E59-67 (2010).
pubmed: 19861585 doi: 10.1152/ajpendo.00385.2009
Krist, J. et al. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes. Facts 6, 57–69 (2013).
pubmed: 23429279 pmcid: 5644751 doi: 10.1159/000348667
Noori-Zadeh, A., Bakhtiyari, S., Khanjari, S., Haghani, K. & Darabi, S. Elevated blood apelin levels in type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res. Clin. Pract. 14, 43–53 (2018).
Hanssens, S. et al. Maternal obesity alters the apelinergic system at the feto-maternal interface. Placenta 39, 41–44 (2016).
pubmed: 26992673 doi: 10.1016/j.placenta.2016.01.006
Sun, J. et al. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: A systematic review and meta-analysis. Lipids Health Dis. 19, 26. https://doi.org/10.1186/s12944-020-01209-7 (2020).
doi: 10.1186/s12944-020-01209-7 pubmed: 32087711 pmcid: 7035755
Ringström, C. et al. Apelin is a novel peptide. Regul. Pept. 162, 44–51 (2010).
pubmed: 20346374 doi: 10.1016/j.regpep.2010.03.005
Han, S. et al. Pancreatic islet APJ deletion reduces islet density and glucose tolerance in mice. Endocrinology 156, 2451–2460 (2015).
pubmed: 25965959 doi: 10.1210/en.2014-1631
Chen, H. et al. Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides 32, 1634–1639 (2011).
pubmed: 21762740 doi: 10.1016/j.peptides.2011.06.025
Gao, L. R. et al. Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats. Stem Cell Res. Ther. 9, 339. https://doi.org/10.1186/s13287-018-1084-x (2018).
doi: 10.1186/s13287-018-1084-x pubmed: 30526660 pmcid: 6286553
Hou, J. et al. Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis. Stem Cell Res. Ther. 8, 215. https://doi.org/10.1186/s13287-017-0673-4 (2017).
doi: 10.1186/s13287-017-0673-4 pubmed: 28962638 pmcid: 5622481
Beamish, C. A. et al. Decrease in Ins
pubmed: 28348115 doi: 10.1530/JOE-16-0475
Friedrichsen, B. N. et al. Expression, biosynthesis and release of preadipocyte factor-1/delta-like protein/fetal antigen-1 in pancreatic β-cells: Possible physiological implications. J. Endocrinol. 176, 257–266 (2003).
pubmed: 12553874 doi: 10.1677/joe.0.1760257
Wu, L. E. et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol. Metab. 3, 465–473 (2014).
pubmed: 24944906 pmcid: 4060222 doi: 10.1016/j.molmet.2014.02.005
Lammert, E. & Thorn, P. The role of the islet niche on beta cell structure and function. J. Mol. Biol. 432, 1407–1418 (2020).
pubmed: 31711959 doi: 10.1016/j.jmb.2019.10.032
Aamodt, K. I. & Powers, A. C. Signals in the pancreatic islet microenvironment influence β cell proliferation. Diabetes Obes. Metab. 19(Suppl 1), 124–136 (2017).
pubmed: 28880471 pmcid: 5679109 doi: 10.1111/dom.13031
Horn, S. et al. Research resource: A dual proteomic approach identifies regulated islet proteins during β-cell mass expansion in vivo. Mol. Endocrinol. 30, 133–143 (2016).
pubmed: 26649805 doi: 10.1210/me.2015-1208
Szlapinski, S. K., Bennett, J., Strutt, B. J. & Hill, D. J. Increased alpha and beta cell mass during mouse pregnancy is not dependent on transdifferentiation. Exp. Biol. Med. 246, 617–628 (2021).
doi: 10.1177/1535370220972686
Huising, M. O., Lee, S. & van der Meulen, T. Evidence for a neogenic niche at the periphery of pancreatic islets. BioEssays 40, e1800119. https://doi.org/10.1002/bies.201800119 (2018).
doi: 10.1002/bies.201800119 pubmed: 30264410 pmcid: 6570402
Masoud, A. G. et al. Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury. J. Clin. Investig. 130, 94–107 (2020).
pubmed: 31738185 doi: 10.1172/JCI128469
Bonner-Weir, S., Aguayo-Mazzucato, C. & Weir, G. C. Dynamic development of the pancreas from birth to adulthood. Upsala J. Med. Sci. 121, 155–158 (2016).
pubmed: 26998806 pmcid: 4900072 doi: 10.3109/03009734.2016.1154906
Yu, M., Feng, H. J., Abdalla, A. M. E., Teng, Y. F. & Li, Q. Apelin-13 promotes late endothelial progenitor cells differentiation by regulating Krüppel-like factor 4. Eur. Rev. Med. Pharmacol. Sci. 23, 7098–7109 (2019).
pubmed: 31486512
Kinjo, T., Higashi, H., Uno, K. & Kuramoto, N. Apelin/apelin receptor system: Molecular characteristics, physiological Roles, and prospects as a target for disease prevention and pharmacotherapy. Curr. Mol. Pharmacol. https://doi.org/10.2174/1874467213666200602133032 (2020).
doi: 10.2174/1874467213666200602133032
Tanday, N., Irwin, N., Moffett, R. C., Flatt, P. R. & O’Harte, F. P. M. Beneficial actions of a long-acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation. Diabetes Obes. Metab. 22, 2468–2478 (2020).
pubmed: 32844576 doi: 10.1111/dom.14177
Guo, L. et al. Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B. Endocr. Res. 34, 142–154 (2009).
pubmed: 19878074 doi: 10.3109/07435800903287079
Sörhede Winzell, M., Magnusson, C. & Ahrén, B. The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul. Pept. 131, 12–17 (2005).
pubmed: 15970338 doi: 10.1016/j.regpep.2005.05.004
Feng, J., Zhao, H., Du, M. & Wu, X. The effect of apelin-13 on pancreatic islet beta cell mass and myocardial fatty acid and glucose metabolism of experimental type 2 diabetic rats. Peptides 114, 1–7 (2019).
pubmed: 30954534 doi: 10.1016/j.peptides.2019.03.006
Carpéné, C. et al. Expanding role for the apelin/APJ system in physiopathology. J. Physiol. Biochem. 63, 359–373 (2007).
pubmed: 18457011 doi: 10.1007/BF03165767
Kawamata, Y. et al. Molecular properties of apelin: Tissue distribution and receptor binding. Biochim. Biophys. Acta 1538, 162–171 (2001).
pubmed: 11336787 doi: 10.1016/S0167-4889(00)00143-9
Barbour, L. A. et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30(Suppl. 2), 112–119 (2007).
doi: 10.2337/dc07-s202
Dawid, M., Mlyczynska, E., Kurowska, P., Sierpowski, M. & Rak, A. Apelin decreased placental hormone secretion by human trophoblast BeWo cells via apelin receptor, protein kinase A and extracellular signal-regulated kinases 1/2 activation. J. Physiol. Pharmacol. https://doi.org/10.26402/jpp.2019.6.08 (2019).
doi: 10.26402/jpp.2019.6.08 pubmed: 32084650
Guo, Y. Y. et al. Circulating levels of Elabela and Apelin in the second and third trimesters of pregnancies with gestational diabetes mellitus. Gynecol. Endocrinol. 2, 1–5 (2020).
Dorrell, C. et al. Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers. Mol. Cell. Endocrinol. 339, 144–150 (2011).
pubmed: 21539888 pmcid: 3112273 doi: 10.1016/j.mce.2011.04.008

Auteurs

Brenda Strutt (B)

Lawson Health Research Institute, St Joseph Health Care, 268 Grosvenor St, London, ON, N6A 4V2, Canada.

Sandra Szlapinski (S)

Lawson Health Research Institute, St Joseph Health Care, 268 Grosvenor St, London, ON, N6A 4V2, Canada.
Department of Physiology and Pharmacology, Western University, London, ON, N6A 3K7, Canada.

Thineesha Gnaneswaran (T)

Department of Physiology and Pharmacology, Western University, London, ON, N6A 3K7, Canada.

Sarah Donegan (S)

Department of Physiology and Pharmacology, Western University, London, ON, N6A 3K7, Canada.

Jessica Hill (J)

Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, EX2 5DW, UK.

Jamie Bennett (J)

Lawson Health Research Institute, St Joseph Health Care, 268 Grosvenor St, London, ON, N6A 4V2, Canada.
Life Sciences Program, School of Interdisciplinary Science, McMaster University, Hamilton, ON, L8S 4LD, Canada.

David J Hill (DJ)

Lawson Health Research Institute, St Joseph Health Care, 268 Grosvenor St, London, ON, N6A 4V2, Canada. david.hill@lawsonresearch.com.
Department of Physiology and Pharmacology, Western University, London, ON, N6A 3K7, Canada. david.hill@lawsonresearch.com.
Departments of Medicine and Paediatrics, Western University, London, ON, N6A 3K7, Canada. david.hill@lawsonresearch.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH